The orthopedic surgeons and researchers of Glasgow Royal Infirmary and the University of Strathclyde in Glasgow, Scotland, found that the system was an effective minimally invasive option.
More Articles on Devices:
FDA Warns NuVasive About Affix Spine Device Marketing
Zimmer Looking to Grow Emerging Orthopedic Markets
500 Invibio PEEK-OPTIMA Devices Cleared for US Use
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
